CareDx, Inc.
CDNA
Positions held
Your positionsCDNA isn't in your positions.
Add it to see shares, cost, and P&L here.
Bull / bear case
Site-generated summary from fundamentals, news, and score — not investment advice. As of 2026-10-08.
- CareDx, Inc. is positioned in the growing diagnostics and research sector, focusing on personalized medicine, which is increasingly important in healthcare.
- Revenue increased by 12% compared to the prior quarter, reaching $132 million.
- Gross margin improved to 73.5%, up from 71.4% in the previous quarter.
- The company has a high debt-to-equity ratio of 4.522, indicating potential financial risk.
- In 2025, CareDx reported a net income loss of $21.354 million, reflecting ongoing profitability challenges.
- Operating margin was negative at -6.601% for the year 2025, highlighting operational inefficiencies.
Fundamentals
| Market cap | $3.22B | Enterprise value | $2.86B | Trailing P/E | 29.91 | Forward P/E | 48.22 |
| PEG | — | Price / book | 7.52 | Beta | 2.38 | Dividend yield | 0.00% |
| Revenue growth | 52.2% | Earnings growth | — | Gross margin | 70.6% | Operating margin | 0.2% |
| Profit margin | 24.2% | ROE | 29.5% | ROA | -0.3% | Debt / equity | 0.05 |
| Current ratio | 4.58 | Free cash flow | $112.16M | Analyst recommendation | buy | Mean target | $58.83 |
| 52w high | $72.51 | 52w low | $13.95 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $132M | $118M | $108M | $100M | $86.7M | — |
| Op margin | 0.2% | 1.5% | -5.6% | -0.2% | -12.4% | — |
| Net income | $111M | $2.8M | -$4.1M | $1.7M | -$8.6M | — |
| Gross margin | 73.5% | 71.4% | 67.2% | 69.4% | 66.9% | — |
| Gross profit | $97.0M | $84.1M | $72.9M | $69.4M | $58.0M | — |
| Operating income | $0.3M | $1.8M | -$6.0M | -$0.2M | -$10.8M | — |
- Revenue +12% vs prior quarter ($132M vs $118M).
- Gross margin 73.5% (was 71.4% prior quarter).
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $380M | $334M | $280M | $322M | — |
| Op margin | -6.6% | -16.6% | -38.2% | -24.0% | — |
| Net income | -$21.4M | $52.5M | -$190M | -$76.6M | — |
| Gross margin | 67.6% | 67.1% | 63.6% | 65.1% | — |
| Gross profit | $257M | $224M | $178M | $210M | — |
| Operating income | -$25.1M | -$55.5M | -$107M | -$77.2M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-09-30 · Consumer Confidence Falls Amid Ongoing Geopolitical Tensions: 4 Picks
2026-09-25 · CareDx (CDNA) Stock Jumps 13.0%: Will It Continue to Soar?
2026-09-24 · CareDx +14% on Fresh $74 Analyst Price Target
2026-09-24 · Zacks.com featured highlights include CareDx, Ciena, Celestica, Materion and MACOM Technology Solutions
2026-09-23 · 5 Top-Ranked High-Efficiency Stocks With Strong Profit Potential
2026-09-14 · 4 Healthcare Stocks to Play Safe as Fed Gears Up for Rate Hike
2026-09-09 · Oil Surge Continues on Escalating Middle East Crisis: 4 Defensive Picks
2026-09-08 · Are Medical Stocks Lagging CareDx (CDNA) This Year?
2026-09-02 · Canaccord Genuity Initiates CareDx at Buy With $65 Price Target
2026-08-27 · CareDx (CDNA) is a Great Momentum Stock: Should You Buy?
2026-08-24 · 3 Medical Service Stocks Resilient Amid Persistent Workforce Shortage
2026-08-23 · CareDx (CDNA) Shares Jumped, So What Is Driving Attention Now?
Price (daily)
Full chart · RSI · MACD · patterns